These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 3803380

  • 1. Susceptibility of Campylobacter species to niridazole.
    Bannatyne RM, Karmali MA, Jackowski J, Roscoe M.
    Eur J Clin Microbiol; 1986 Dec; 5(6):664-5. PubMed ID: 3803380
    [No Abstract] [Full Text] [Related]

  • 2. Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coli.
    Hof H, Rieffert M, Sticht-Groh V, Zak O, Schweizer EH.
    Antimicrob Agents Chemother; 1984 Oct; 26(4):498-500. PubMed ID: 6517542
    [Abstract] [Full Text] [Related]

  • 3. Antibacterial effects of niridazole: its effect on microaerophilic campylobacter.
    Hof H, Sticht-Groh V.
    Infection; 1984 Oct; 12(1):36-9. PubMed ID: 6706411
    [Abstract] [Full Text] [Related]

  • 4. In vitro susceptibilities of 40 Campylobacter fetus subsp. jejuni strains to niridazole and metronidazole.
    Freydière AM, Gille Y, Tigaud S, Vincent P.
    Antimicrob Agents Chemother; 1984 Jan; 25(1):145-6. PubMed ID: 6703680
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria.
    Hof H, Sticht-Groh V, Müller KM.
    Antimicrob Agents Chemother; 1982 Aug; 22(2):332-3. PubMed ID: 6927288
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter fetus subsp. fetus to eight cephalosporins with special reference to species differentiation.
    Karmali MA, De Grandis S, Fleming PC.
    Antimicrob Agents Chemother; 1980 Dec; 18(6):948-51. PubMed ID: 7235681
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial susceptibility of Campylobacter jejuni isolated from humans with diarrhoea and from healthy chickens.
    Svedhem A, Kaijser B, Sjögren E.
    J Antimicrob Chemother; 1981 Mar; 7(3):301-5. PubMed ID: 7275880
    [No Abstract] [Full Text] [Related]

  • 8. In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Austria to erythromycin and ciprofloxacin.
    Hirschl AM, Wolf D, Berger J, Rotter ML.
    Zentralbl Bakteriol; 1990 Apr; 272(4):443-7. PubMed ID: 2360966
    [Abstract] [Full Text] [Related]

  • 9. Bactericidal activity of antibiotics against Campylobacter fetus subspecies intestinalis.
    Spelhaug DR, Gilchrist MJ, Washington JA.
    J Infect Dis; 1981 Mar; 143(3):500. PubMed ID: 6262415
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Examination of the antibacterial action of metronidazole against vibrios and Campylobacter (author's transl)].
    Füzi M.
    Zentralbl Bakteriol A; 1981 Mar; 249(2):242-6. PubMed ID: 7269853
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility of Campylobacter fetus subsp. jejuni, isolated from patients in Jakarta, Indonesia to ten antimicrobial agents.
    Ringertz S, Rockhill RC, Ringertz O.
    J Antimicrob Chemother; 1981 Oct; 8(4):333-6. PubMed ID: 7298551
    [No Abstract] [Full Text] [Related]

  • 14. Sensitivity of campylobacter isolates to clavulanate-potentiated amoxycillin.
    Corbel MJ, Ibrahim ME, Gill KP.
    Vet Rec; 1984 Nov 03; 115(18):465. PubMed ID: 6568786
    [No Abstract] [Full Text] [Related]

  • 15. [Antibiotic sensitivity of Campylobacter jejuni and Campylobacter coli strains with special reference to sensitivity to erythromycin and neomycin].
    Richter U, Mochmann H, Scholz H.
    Padiatr Grenzgeb; 1989 Nov 03; 28(1):57-60. PubMed ID: 2710556
    [Abstract] [Full Text] [Related]

  • 16. Effect of erythromycin on the fecal excretion of Campylobacter fetus subspecies jejuni.
    Pitkanen T, Pettersson T, Pomka A, Kosunen TU.
    J Infect Dis; 1982 Jan 03; 145(1):128. PubMed ID: 7054315
    [No Abstract] [Full Text] [Related]

  • 17. [Difference in oxygen requirements between the metronidazole-sensitive parent strain and its resistant variant of Campylobacter jejuni].
    Narikawa S, Nakashio S, Koinuma I, Harasawa I, Nakamura M, Yoshizaki E, Kamiki T.
    Nihon Saikingaku Zasshi; 1982 May 03; 37(3):619-21. PubMed ID: 7131777
    [No Abstract] [Full Text] [Related]

  • 18. Studies of the microaerophilic nature of Campylobacter fetus subsp. jejuni. I. Physiological aspects of enhanced aerotolerance.
    Hoffman PS, Krieg NR, Smibert RM.
    Can J Microbiol; 1979 Jan 03; 25(1):1-7. PubMed ID: 427650
    [No Abstract] [Full Text] [Related]

  • 19. Susceptibility of Campylobacter fetus subsp. jejuni to paromomycin.
    Freydiere AM, Barbé G, Gille Y, Vincent P.
    Eur J Clin Microbiol; 1984 Aug 03; 3(4):322-3. PubMed ID: 6489324
    [No Abstract] [Full Text] [Related]

  • 20. Antibacterial activity of niridazole against Salmonellae.
    Bannatyne RM, Jackowski J, Grant RB.
    Antimicrob Agents Chemother; 1986 May 03; 29(5):923-4. PubMed ID: 3729350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.